10 years ago, St. Jude took on pediatric cancer genome, and won
Dr. James Downing, president and CEO of St. Jude Children's Research Hospital, has been instrumental in the development and refinement of St. Jude's genomic sequencing operations for pediatric cancer. (Patrick Lantrip/Daily Memphian)
Among the findings was genetic coding that proved there is more than a passing chance that some cancers are inherited.
Topics
Dr. James Downing St. Jude Children’s Research Hospital Pediatric Cancer Genome ProjectJane Roberts
Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers business news and features for The Daily Memphian.
Want to comment on our stories or respond to others? Join the conversation by subscribing now. Only paid subscribers can add their thoughts or upvote/downvote comments. Our commenting policy can be viewed here.